Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Assandri

Showing results (31-40 of 52) with videos related to

Pageof 6
Sort By:
European Journal of Drug Metabolism and Pharmacokinetics|April 1, 1986
Disposition of premazepam, an anti-anxiety pyrrolodiazepine, in the cynomolgus monkeyG Zanolo, M C Giachetti, S Canali, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1985
Contragestational profile of the tumor-inhibiting agent, L-alanosine, in the rat and the hamsterG Galliani, A Assandri, D Barone, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|January 1, 1985
Metabolic fate of zetidoline, a new neuroleptic agent, in manA Assandri, A Perazzi, P Ferrari, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|October 25, 2002
Pharmacokinetic and mass balance study of unlabelled and (14)C-labelled emedastine difumarate in healthy volunteersM Brunner, K Kletter, A Assandri, et al.
Arzneimittel-Forschung|January 1, 1981
Influence of metabolism on the activity of a new anti-fertility agent, 2-(3-ethoxyphenyl)-5,6-dihydro-s-triazolo [5,1-a]isoquinoline (DL 204-IT), in the rat and the hamsterA Assandri, A Perazzi, E Martinelli, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|January 1, 1982
Species differences in the disposition and metabolism of 1-methyl-3-(3-pyridyl)-5-(2-hydroxy-methylphenyl)-1H-1,2,4-triazole, a potential sedative-hypnotic compoundA Assandri, A Omodei-Salè, P Ferrari, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 1, 1984
Metabolic fate of premazepam, a new anti-anxiety drug, in the rat and the dogA Assandri, D Barone, P Ferrari, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|May 1, 1984
Pharmacokinetics and metabolism of premazepam, a new potential anxiolytic, in humansB Vitiello, G Buniva, A Bernareggi, et al.
Antimicrobial Agents and Chemotherapy|March 16, 2011
Systemic absorption of rifamycin SV MMX administered as modified-release tablets in healthy volunteersA F D Di Stefano, A Rusca, L Loprete, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 1, 1984
Metabolism of the neuroleptic agent zetidoline in the rat and the dogA Assandri, A Perazzi, L Fontanella, et al.
Pageof 6

Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
European Journal of Drug Metabolism and Pharmacokinetics|April 1, 1986
Disposition of premazepam, an anti-anxiety pyrrolodiazepine, in the cynomolgus monkeyG Zanolo, M C Giachetti, S Canali, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1985
Contragestational profile of the tumor-inhibiting agent, L-alanosine, in the rat and the hamsterG Galliani, A Assandri, D Barone, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|January 1, 1985
Metabolic fate of zetidoline, a new neuroleptic agent, in manA Assandri, A Perazzi, P Ferrari, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|October 25, 2002
Pharmacokinetic and mass balance study of unlabelled and (14)C-labelled emedastine difumarate in healthy volunteersM Brunner, K Kletter, A Assandri, et al.
Arzneimittel-Forschung|January 1, 1981
Influence of metabolism on the activity of a new anti-fertility agent, 2-(3-ethoxyphenyl)-5,6-dihydro-s-triazolo [5,1-a]isoquinoline (DL 204-IT), in the rat and the hamsterA Assandri, A Perazzi, E Martinelli, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|January 1, 1982
Species differences in the disposition and metabolism of 1-methyl-3-(3-pyridyl)-5-(2-hydroxy-methylphenyl)-1H-1,2,4-triazole, a potential sedative-hypnotic compoundA Assandri, A Omodei-Salè, P Ferrari, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 1, 1984
Metabolic fate of premazepam, a new anti-anxiety drug, in the rat and the dogA Assandri, D Barone, P Ferrari, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|May 1, 1984
Pharmacokinetics and metabolism of premazepam, a new potential anxiolytic, in humansB Vitiello, G Buniva, A Bernareggi, et al.
Antimicrobial Agents and Chemotherapy|March 16, 2011
Systemic absorption of rifamycin SV MMX administered as modified-release tablets in healthy volunteersA F D Di Stefano, A Rusca, L Loprete, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 1, 1984
Metabolism of the neuroleptic agent zetidoline in the rat and the dogA Assandri, A Perazzi, L Fontanella, et al.
Pageof 6